Pierre Dubois: Low drug prices could threaten future investment and innovation
In May, French economist Pierre Dubois of the Toulouse School of Economics led one of the seminars in the MUNI Seminar Series on the topic of Pharmaceutical Regulation and Incentives for Innovation in an International Context. In an interview with ECON MUNI, he explained why low drug prices could threaten future investment in research and development, how European pharmaceutical market regulation works, and why European countries risk losing access to innovative treatments.